🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

BD Deal for Parata Systems Seen as Another Step Forward in Transformation

Published 07/06/2022, 04:08 am
© Reuters.
BDX
-

By Sam Boughedda

Becton, Dickinson and Company (NYSE:BDX) announced Monday that it has agreed on a deal with Frazier Healthcare Partners to acquire Parata Systems, a provider of pharmacy automation solutions, for $1.525 billion.

BD, a medical technology company, said the all-cash transaction is expected to close by the end of the first half of BD's fiscal year 2023, expanding its solutions to provide new pharmacy automation technologies.

"Parata expands BD's solutions to a new area of the high-growth pharmacy automation space and is a prime example of BD executing our disciplined M&A strategy," said Tom Polen, chairman, chief executive officer and president of BD. "Parata has a highly attractive financial profile and compelling value proposition that meets all of our rigorous investment criteria on growth, profitability and returns."

Following the announcement, Stifel analyst Rick Wise said that for some time, BD has emphasized its 2025 strategy, centered in part upon shedding lower growth assets such as diabetes care and moving towards faster-growth transformative solutions.

"We view this transaction as another positive step forward in the multi-faceted BD transformation," said the analyst.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.